共酶Q10和维生素E组合在角膜新血管化中的抗血管作用:一项试点研究
Armağan Özgür1,2, Mehmet Cüneyt Özmen2, Duygu Yalınbaş Yeter3
1Department of Ophthalmology, Ankara Bilkent City Hospital, Ankara, Turkiye.
概括
同酶Q10 (CoQ10) 和维生素E (Vit E) 眼科溶液 (Coqun) 在子中显示出显著的角膜新血管化 (CoNV) 回归. 虽然bevacizumab更有效,但Coqun提供了潜在的好处,特别是当绿眼共存时.
科学领域:
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 角膜新血管化 (CoNV) 对视力构成重大威胁.
- 目前对冠状病毒的治疗有局限性.
- 需要新的治疗药物来有效地管理CovNV.
研究的目的:
- 为了比较子结膜辅酶Q10 (CoQ10) 和维生素E (Vit E) 眼液 (Coqun) 与贝瓦齐祖马布的疗效,在模型中进行了针诱导的CoNV.
- 为了评估Coqun对CoNV回归的剂量依赖作用.
主要方法:
- 在子中使用丝 sutures诱导角膜新血管化 (CoNV).
- 子接受了平衡盐溶液 (对照组),贝瓦西祖马布或两剂Coqun.conjunctival注射.
- 角膜新血管化 (CoNV) 回归通过摄影分析和细胞病理学量化.
主要成果:
- 与对照组相比,所有治疗组都表现出显著的CoNV减少.
- 贝瓦西祖马布实现了最高的回归率 (87.8%).
- 科昆显示实质性回归 (69.5%和67.1%的两个剂量) 没有显著的剂量差异.
结论:
- 副结膜Coqun是角膜新血管化 (CoNV) 的潜在辅助疗法.
- 由于其神经保护性质,Coqun具有治疗价值,特别是在共存的疾病中,如玻璃眼,由于其神经保护性质.
- 建议进行进一步的临床研究,以确定Coqun在治疗CoNV.中的作用.
相关概念视频
01:28Angle Closure Glaucoma: Treatment
448
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
448
01:27Open Angle Glaucoma: Treatment
403
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
403
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:26Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
01:25Glaucoma: Overview
527
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
527
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
490
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
490